Publications by authors named "Manali Parulekar"

Claim this Profile
B
Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma (BEER BTC): A Multicenter, Open-Label, Randomized, Phase II Trial.
Anant Ramaswamy, Prabhat Bhargava, Sujay Srinivas, Akhil Kapoor, Bal Krishna Mishra, Manali Parulekar

J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer: A Randomized Clinical Trial.
Vikas Ostwal, Shraddha Patkar, Reena Engineer, Manali Parulekar, Sarika Mandavkar

JAMA Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial.
Vikas Ostwal, Anant Ramaswamy, Sarika Mandavkar, Prabhat Bhargava, Deepali Naughane, Manali Parulekar

JAMA Netw Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers.
Anant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, Anuj Gupta, Akhil Kapoor, Manali Parulekar

JNCI Cancer Spectr· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine, Cisplatin, and Nab-Paclitaxel as a First-Line Therapy for Advanced Biliary Tract Cancers.
Sandeep Gedela, Pritesh Munot, Arvind Vaidyanathan, Ritam Joarder, Deepali Chaugule, Manali Parulekar

J Gastrointest Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB).
Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava, Sujay Srinivas, Akhil Kapoor, Manali Parulekar

J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT).
Anant Ramaswamy, Vikas Ostwal, Atul Sharma, Prabhat Bhargava, Sujay Srinivas, Manali Parulekar

JAMA Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis